Accelerate to discover

Back to filter

Related topics

Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility

Cytek Biosciences

Jun 21, 2021

6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full spectrum flow cytometer for their...

Jun 21, 2021

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

Spectral Instruments Imaging

Jun 8, 2021

This work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in LUSC, and suggests that...

PMOD Virtual User Meeting

Bruker Biospin

Jun 7, 2021

We look forward to welcoming many of our users to 2021 PMOD User Meeting. The theme of our PMOD User Meeting will be...

IncuCyte webinar recording: How to measure Immune Cell Killing of Tumor Cells effectively

Sartorius

Jun 4, 2021

Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO pipeline continues to...

Jun 21, 2021

White Paper: Immunophenotyping Rare Immune Cells with Laminar Wash AUTO System

Curiox

Jun 3, 2021

The Laminar Wash (LW) AUTO system consists of a wall-less plate and a laminar flow cell washer that enable automated...

Show all topics (10)

Micro-CT: Fancy gadget or indispensable technology towards quantification of lung diseases?

Jul 29, 2020

Lung diseases such as fibrosis, viral infection and cancer are life-threatening conditions for which our knowledge on etiology and/or effective treatment options still contains important gaps. To unravel disease processes and to test novel therapeutic approaches, investigators typically rely on end-stage procedures (such as serum analysis, cyto-/chemokine profiles and selective tissue histology from animal models). These techniques are useful but provide only a snapshot of disease processes that are essentially dynamic in time and space. Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of lung disease progression and treatment. Computed tomography (CT) is a clinical standard and can have enormous benefits in a research context too. Yet, its implementation in basic and preclinical research laboratories lags behind. Nevertheless, the evidence for the benefits of micro-CT as an indispensable and safe tool to repeatedly evaluate lung disease progression and therapy efficacy in live animals is nothing but convincing.

Do you want to learn more? Watch this recorded webinar or ask us!

Technical breakthrough
Application
Webinar

Related technologies: X-ray and micro computed tomography

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

In-vivo micro-CT with the world's highest spatial resolution

show detail

The world’s fastest, low-dose, high-resolution micro-CT

show detail

The high performance, stand-alone, fast, desk-top in vivo micro-CT

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey